91九色视频

header-logo
Radiation Oncology Banner
Radiation Oncology
Sarah Kerns, PhD, MPH

Sarah Kerns, PhD, MPH

Associate Professor, Radiation Oncology; Secondary Appointment, School of Graduate Studies

Locations

  • Radiation Oncology

Contact Information

Education

MPH, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2008
PhD, Northwestern University Feinberg School of Medicine, Chicago, IL, 2007
BS, University of Wisconsin-Madison, Madison, WI, 2002

Biography

Training

  • 07/15/2008 - 05/15/2009 Intern, Health and Nutrition Unit, Society for Elimination of Rural Poverty (SERP),
    Hyderabad, India
  • 07/01/2009 - 06/30/2011 Postdoctoral Fellow, Human Genetics, New York University Langone Medical
    Center, 550 1st Ave, New York, NY 
  • 07/01/2012 - 08/15/2013 Postdoctoral Fellow, Radiation Oncology, Icahn School of Medicine at Mount Sinai,
    1 Gustave L. Levy Pl, New York, NY 

Research Interests

Dr. Kerns studies genetic and other host factors that predispose patients to development of adverse reactions to cancer therapy, primarily radiotherapy. The goals of this work are to identify novel targets for prevention of radiation side effects and to develop risk prediction models that could be used to personalize cancer treatment.

View the Kerns Laboratory

Publications

  • (Farazi M, Yang X, Gehl CJ, Barnett GC, Burnet NG, Chang-Claude J, Parker CC, Dunning AM, Azria D, Choudhury A, Rancati T, De Ruysscher D, Seibold P, Sperk E, Talbot CJ, Veldeman L, Webb AJ, Elliott R, Aguado-Barrera ME, Carballo AM, Fuentes-Ríos O, Gómez-Caamaño A, Peleteiro P, Vega A, Ostrer H, Rosenstein BS, Saito S, Parliament M, Usmani N, Marples B, Chen Y, Morrow G, Messing E, Janelsins MC, Hall W, West CML, Auer PL, Kerns S.) Cancer Epidemiol Biomarkers Prev. 2025 Mar 03 PMID: 40029246 03/03/2025

  • (Kerns SL, Dinh PC Jr, Monahan PO, Stump T, Fung C, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Huddart R, Kollmannsberger C, Martin NE, Nevel K, Kincaid J, Einhorn LH, Travis LB.) J Natl Cancer Inst. 2025 Feb 03 PMID: 39898813 02/03/2025

  • (Mcwilliam A, Marshall D, Kerns SL, Barnett GC, Vega A, Kapouranis T, Aguado Barrera ME, Avuzzi B, Azria D, Chang-Claude J, Choudhury A, Coedo Costa C, Dunning A, Farcy-Jacquet MP, Faivre-Finn C, Gutiérrez-Enríquez S, Fuentes Río O, Gómez Caamaño A, Lambrecht M, López Pleguezuelos C, Rancati T, Rattay T, De Ruysscher D, Seibold P, Sperk E, Talbot C, Webb A, Veldeman L, Rosenstein BS, West CML, REQUITE Consortium.) J Natl Cancer Inst. 2025 Jan 06 PMID: 39761002 01/06/2025

  • (West CML, Marignol L, Kerns SL.) Basic Clinical Radiobiology, Sixth Edition. 1 January 2025:237-249 SCOPUS ID: 2-s2.0-85212733615 01/01/2025

  • (Bouzaki A, Green D, van Herk M, Shortall J, Puri T, Kerns S, Azria D, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, Lambrecht M, Avuzzi B, Ruysscher DD, Seibold P, Sperk E, Talbot C, Vega A, Veldeman L, Webb A, Rosenstein B, West CM, Gioscio E, Rancati T, Osorio EV, McWilliam A.) Physics and Imaging in Radiation Oncology. January 2025;33 SCOPUS ID: 2-s2.0-85215853089 01/01/2025

  • (Kullo IJ, Conomos MP, Nelson SC, Adebamowo SN, Choudhury A, Conti D, Fullerton SM, Gogarten SM, Heavner B, Hornsby WE, Kenny EE, Khan A, Khera AV, Li Y, Martin I, Mercader JM, Ng M, Raffield LM, Reiner A, Rowley R, Schaid D, Stilp A, Wiley K, Wilson R, Witte JS, Natarajan P, Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium.) Am J Hum Genet. 2024 Dec 05;111(12):2594-2606 PMID: 39561770 PMCID: PMC11639095 SCOPUS ID: 2-s2.0-85210411516 11/20/2024

  • (Gehl CJ, Verhagen NB, Shaik TJ, Nimmer K, Yang X, Xing Y, Taylor BW, Nataliansyah MM, Kerns SL, Kothari AN.) J Am Coll Surg. 2024 Dec 01;239(6):539-546 PMID: 38920308 SCOPUS ID: 2-s2.0-85216036137 06/26/2024

  • (Rosenstein BS, Yamoah K, Bentzen SM, Kerns SL, McDonald JT, West CML, Vega A, Rattay T, Ricks-Santi LJ, Radiogenomics Consortium.) Int J Radiat Oncol Biol Phys. 2024 Nov 15;120(4):1107-1110 PMID: 39424580 SCOPUS ID: 2-s2.0-85206214409 10/19/2024

  • (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E.) Int J Radiat Oncol Biol Phys. 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024

  • (Sun Y, Tsai Y, Wood R, Shen B, Chen J, Zhou Z, Zeng G, Marples B, Kerns S, Chen Y.) Int J Radiat Oncol Biol Phys. 2024 May 01;119(1):251-260 PMID: 38008196 PMCID: PMC11934913 SCOPUS ID: 2-s2.0-85180584261 11/27/2023

  • (Liebenberg N, McWilliam A, Kerns SL, Marshall DC, West CM.) BMJ Oncol. 2024 Jan;3(1) PMID: 39524982 PMCID: PMC11256021 11/14/2024

  • (Cui W, Plett PA, Sharma GP, Kerns S, MacVittie TJ.) Front Public Health. 2024;12:1471228 PMID: 39234079 PMCID: PMC11372479 SCOPUS ID: 2-s2.0-85203343450 09/05/2024

Publications of from the

© 2025 91九色视频.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination Statement
The 91九色视频 (91九色视频) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the 91九色视频 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. 91九色视频’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.

Notice of Compliance with Laws and Commitment to Civil Rights
The 91九色视频 is committed to full compliance with all applicable federal, state, and local laws and regulations in the pursuit of our missions. Consistent with recent federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making. As part of this commitment, we are actively reviewing our policies and materials to ensure they align with federal nondiscrimination obligations.